Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Brian Lowes"'
Autor:
Arif Albulushi, Desmond Boakye Tanoh, Ahmed Almustafa, Nadya Al Matrooshi, Ronald Zolty, Brian Lowes
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background Heart failure with preserved ejection fraction (HFpEF) is common in type 2 diabetes mellitus (T2D), leading to high morbidity and mortality. Managing HFpEF in diabetic patients is challenging with limited treatments. Sodium-glucos
Externí odkaz:
https://doaj.org/article/ad3d0b56410c49c29f17f77dcdea7fc7
Autor:
Hanyu Ni, Elizabeth Jordan, Daniel D. Kinnamon, Jinwen Cao, Garrie J. Haas, Mark Hofmeyer, Evan Kransdorf, Gregory A. Ewald, Alanna A. Morris, Anjali Owens, Brian Lowes, Douglas Stoller, W.H. Wilson Tang, Sonia Garg, Barry H. Trachtenberg, Palak Shah, Salpy V. Pamboukian, Nancy K. Sweitzer, Matthew T. Wheeler, Jane E. Wilcox, Stuart Katz, Stephen Pan, Javier Jimenez, Daniel P. Fishbein, Frank Smart, Jessica Wang, Stephen S. Gottlieb, Daniel P. Judge, Charles K. Moore, Gordon S. Huggins, Ray E. Hershberger
Publikováno v:
Journal of the American College of Cardiology. 81:2059-2071
Autor:
Barry H. Trachtenberg, Javier Jimenez, Alanna A. Morris, Evan Kransdorf, Anjali Owens, Daniel P. Fishbein, Elizabeth Jordan, Daniel D. Kinnamon, Jonathan O. Mead, Gordon S. Huggins, Ray E. Hershberger, Garrie Haas, Daniel Fishbein, Stephen S. Gottlieb, Matthew T. Wheeler, Mark Hofmeyer, W. H. Wilson Tang, Anjali T. Owens, Charles K. Moore, Javier Jimenez Carcamo, Barry Trachtenberg, Nancy K. Sweitzer, Palak Shah, Brian Lowes, Douglas Stoller, Frank Smart, Jane Wilcox, Stuart Katz, Gregory A. Ewald, Keith D. Aaronson, Jessica J. Wang, Salpy Pamboukian, Daniel P. Judge, Evan P. Kransdorf, Sonia Garg, Patrice Desvigne-Nickens, James Troendle, Yi-Ping Fu, Lucia Hindorff
Publikováno v:
Genetics in Medicine. 24:1495-1502
The cardiac phenotype of hereditary transthyretin amyloidosis (hTTR) usually presents as a restrictive or hypertrophic cardiomyopathy, and, although rarely observed as dilated cardiomyopathy (DCM), TTR is routinely included in DCM genetic testing pan
Publikováno v:
Current Problems in Cardiology. 48:101627
Publikováno v:
Journal of Cardiac Failure. 29:632
Autor:
Muhannad A. Abbasi, Douglas Stoller, Elizabeth Lyden, Brian Lowes, Ronald Zolty, Scott Lundgren
Publikováno v:
Journal of Cardiac Failure. 29:632
Autor:
Gordon S, Huggins, Daniel D, Kinnamon, Garrie J, Haas, Elizabeth, Jordan, Mark, Hofmeyer, Evan, Kransdorf, Gregory A, Ewald, Alanna A, Morris, Anjali, Owens, Brian, Lowes, Douglas, Stoller, W H Wilson, Tang, Sonia, Garg, Barry H, Trachtenberg, Palak, Shah, Salpy V, Pamboukian, Nancy K, Sweitzer, Matthew T, Wheeler, Jane E, Wilcox, Stuart, Katz, Stephen, Pan, Javier, Jimenez, Keith D, Aaronson, Daniel P, Fishbein, Frank, Smart, Jessica, Wang, Stephen S, Gottlieb, Daniel P, Judge, Charles K, Moore, Jonathan O, Mead, Hanyu, Ni, Wylie, Burke, Ray E, Hershberger
Publikováno v:
JAMA. 327(5)
Idiopathic dilated cardiomyopathy (DCM) aggregates in families, and early detection in at-risk family members can provide opportunity to initiate treatment prior to late-phase disease. Most studies have included only White patients, yet Black patient
Autor:
Arif Albulushi, Daniel Zolty, Kajari Dhar, Adam Burdorf, Douglas Stoller, Marshall Hyden, Brian Lowes, Ronald Zolty
Publikováno v:
Journal of the American College of Cardiology. 75:2103
Cyclic guanosine monophosphate (cGMP) plays an important role as pulmonary vasodilator and currently there are targeted therapy to stimulate cGMP in the management of patients with pulmonary hypertension. It is known that patients with pulmonary hype
Autor:
Josef Stehlik, Quinn Wells, Adrian F. Hernandez, Alexandros Briasoulis, Juan Vilaro, Anuradha (Anu) Lala, Peter M. Eckman, Kurt G. Barringhaus, Ravi Dhingra, Xian Shen, Haolin Xu, Jo E. Rodgers, Emily C. O'Brien, Tamas Alexy, Marc A. Simon, Shannon M. Dunlay, Robert J. Mentz, Martha Abshire, Johana Espinoza, Brian Lowes, Rosalia Blanco, Carol I. Duffy, Laine Thomas, Bhanu Gupta
Publikováno v:
Journal of the American College of Cardiology. 75:810
PARADIGM-HF showed that sacubitril/valsartan (sac/val) improved quality of life (QOL) vs enalapril in heart failure with reduced ejection fraction (HFrEF), yet limited data are available regarding QOL changes after sac/val initiation in routine pract
Autor:
Marshall Hyden, Scott Lundgren, John Um, Douglas Stoller, Ronald Zolty, Adam Burdorf, Elizabeth Lyden, Brian Lowes
Publikováno v:
Journal of Cardiac Failure. 25:S178-S179
Introduction Digoxin use within the heart failure population remains controversial, as studies have suggested increased arrhythmia risk and lower survival. Despite decades of use in heart failure, little is known regarding digoxin utilization post-le